|
1
|
Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer.
|
J Gynecol Oncol
|
2008
|
1.06
|
|
2
|
Expression profile of histone deacetylases 1, 2 and 3 in ovarian cancer tissues.
|
J Gynecol Oncol
|
2008
|
0.99
|
|
3
|
Fertility-sparing surgery for young women with early-stage epithelial ovarian cancer.
|
Gynecol Obstet Invest
|
2013
|
0.96
|
|
4
|
Primary yolk sac tumor of the omentum: a case report and review of the literature.
|
Arch Gynecol Obstet
|
2008
|
0.92
|
|
5
|
Update on treatment of uterine sarcoma.
|
Curr Opin Obstet Gynecol
|
2010
|
0.92
|
|
6
|
Risk assessment tool for distant recurrence after platinum-based concurrent chemoradiation in patients with locally advanced cervical cancer: a Korean gynecologic oncology group study.
|
J Clin Oncol
|
2012
|
0.91
|
|
7
|
Efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay in patients with epithelial ovarian cancer.
|
J Gynecol Oncol
|
2009
|
0.89
|
|
8
|
The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells.
|
J Gynecol Oncol
|
2010
|
0.87
|
|
9
|
The relationship between cisplatin resistance and histone deacetylase isoform overexpression in epithelial ovarian cancer cell lines.
|
J Gynecol Oncol
|
2012
|
0.85
|
|
10
|
Is chemotherapy-induced neutropenia a prognostic factor in patients with ovarian cancer?
|
Acta Obstet Gynecol Scand
|
2010
|
0.84
|
|
11
|
Fatal Ifosfamide-induced metabolic encephalopathy in patients with recurrent epithelial ovarian cancer: report of two cases.
|
Cancer Res Treat
|
2011
|
0.83
|
|
12
|
Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy.
|
Gynecol Oncol
|
2012
|
0.82
|
|
13
|
Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma.
|
Arch Gynecol Obstet
|
2012
|
0.81
|
|
14
|
Prognostic significance of stromal microinvasion in the intestinal type of ovarian mucinous adenocarcinoma.
|
Ann Surg Oncol
|
2011
|
0.79
|
|
15
|
Laparoscopic management of early-stage malignant nonepithelial ovarian tumors: surgical and survival outcomes.
|
Int J Gynecol Cancer
|
2013
|
0.79
|
|
16
|
Management of the elderly patient with gynecologic cancer: report of the 2011 workshop in geriatric gynecologic oncology.
|
Int J Gynecol Cancer
|
2012
|
0.79
|
|
17
|
Preoperative fluorine 18 fluorodeoxyglucose tumoral uptake ratio between upper and lower abdomen in primary advanced-stage ovarian cancer.
|
Int J Gynecol Cancer
|
2013
|
0.78
|
|
18
|
The role of loop electrosurgical excisional procedure in the management of adenocarcinoma in situ of the uterine cervix.
|
Eur J Obstet Gynecol Reprod Biol
|
2009
|
0.78
|
|
19
|
Paratubal serous borderline tumor.
|
J Gynecol Oncol
|
2011
|
0.75
|
|
20
|
Stratification of risk groups according to survival after recurrence in endometrial cancer patients.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
21
|
Identification of a preoperative predictive factor for lymph node metastasis in uterine papillary serous carcinoma: long-term results from a single institution.
|
Int J Gynecol Cancer
|
2015
|
0.75
|
|
22
|
Erratum: Author correction.
|
Obstet Gynecol Sci
|
2017
|
0.75
|
|
23
|
Preoperative Predictive Factors for Complete Cytoreduction and Survival Outcome in Epithelial Ovarian, Tubal, and Peritoneal Cancer After Neoadjuvant Chemotherapy.
|
Int J Gynecol Cancer
|
2017
|
0.75
|
|
24
|
Investigation of New Therapeutic Targets in Undifferentiated Endometrial Sarcoma.
|
Gynecol Obstet Invest
|
2017
|
0.75
|